Dopamine agonist

WikiDoc Resources for Dopamine agonist
Articles
Most recent articles on Dopamine agonist Most cited articles on Dopamine agonist Review articles on Dopamine agonist Articles on Dopamine agonist in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dopamine agonist Images of Dopamine agonist Photos of Dopamine agonist Podcasts & MP3s on Dopamine agonist Videos on Dopamine agonist
Evidence Based Medicine
Cochrane Collaboration on Dopamine agonist Bandolier on Dopamine agonist TRIP on Dopamine agonist
Clinical Trials
Ongoing Trials on Dopamine agonist at Clinical Trials.gov Trial results on Dopamine agonist Clinical Trials on Dopamine agonist at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dopamine agonist NICE Guidance on Dopamine agonist NHS PRODIGY Guidance FDA on Dopamine agonist CDC on Dopamine agonist
Books
Books on Dopamine agonist
News
Dopamine agonist in the news Be alerted to news on Dopamine agonist News trends on Dopamine agonist
Commentary
Blogs on Dopamine agonist
Definitions
Definitions of Dopamine agonist
Patient Resources / Community
Patient resources on Dopamine agonist Discussion groups on Dopamine agonist Patient Handouts on Dopamine agonist Directions to Hospitals Treating Dopamine agonist Risk calculators and risk factors for Dopamine agonist
Healthcare Provider Resources
Symptoms of Dopamine agonist Causes & Risk Factors for Dopamine agonist Diagnostic studies for Dopamine agonist Treatment of Dopamine agonist
Continuing Medical Education (CME)
CME Programs on Dopamine agonist
International
Dopamine agonist en Espanol Dopamine agonist en Francais
Business
Dopamine agonist in the Marketplace Patents on Dopamine agonist
Experimental / Informatics
List of terms related to Dopamine agonist

Overview

A dopamine agonist is a compound that activates dopamine receptors, mimicking the effect of the neurotransmitter dopamine.

Uses

Some medical drugs act as dopamine agonists; they are typically used for treating Parkinson's disease, and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA approved for the treatment of RLS.

There is also an ongoing clinical trial to test the effectiveness of Requip (Ropinirole), a dopamine agonist, in reversing the symptoms of SSRI induced sexual dysfunction.

Examples

Examples of dopamine agonists include:

• Parlodel (bromocriptine)
• Permax (Pergolide) - Removed from market March 29,2007.

• Mirapex (Pramipexole)
• Requip (Ropinirole)
• Apokyn (apomorphine)

See also

• Agonist

External links

• Dopamine+Agonists at the US National Library of Medicine Medical Subject Headings (MeSH)